CTRI/2026/07/113979进行中（未招募）不适用
Comparative evaluation of the effects of two versus four temporary skeletal anchorage devices TSADs on the rate of intrusion and retraction of maxillary anteriors - an invivo study - NIL
Dr Pooja Chute0 个研究点目标入组 22 人开始时间: 2026年7月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients having deep bite requiring maxillary incisor intrusion as a part of the orthodontic
- •Patients undergoing orthodontic treatment with fixed appliances.
- •Need for maxillary first premolars extraction.
排除标准
- •Periodontally compromised cases
- •Abnormal root morphology, root resorption, or any trauma with maxillary anteriors
- •Patients with periapical pathology with maxillary anteriors
- •Presence of any systemic disease
研究者
相似试验
已完成
1 期
A research study comparing the effect of different dosing conditions on blood levels of semaglutide in a new tablet composition in healthy participantsType 2 Diabetes2023-503949-65-00Novo Nordisk A/S120
招募中
1 期
An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation2023-507630-25-00Ferring Pharmaceuticals A/S600
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118